Trial Following Subjects Bilaterally Implanted With Mini Well Ready For 2 Years After the Second Eye Implant

March 17, 2021 updated by: SIFI SpA

Retrospective, Observational, Monocenter And Single-Arm Trial Following Subjects Bilaterally Implanted With Mini Well Ready For 2 Years After The Second Eye Implant

The study objective is to evaluate the visual performance of MINI WELL Ready at 24 months following the second eye implant. The objectives of safety are to evaluate the rate of Secondary Surgical Interventions related to the optical properties of the IOL for first and second operative eye separately at 24 months and the rate of visual disturbances and distortions as reported by the subjects as detected by using the Halo & Glare Simulator.

Study Overview

Status

Completed

Conditions

Detailed Description

The present post-.market follow-up study (PSM8 sub-study) is an ancillary study of the PSM8 post market clinical trial (NCT02740010)

Study Type

Observational

Enrollment (Actual)

23

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bari, Italy, 70121
        • U.O. Oftalmologia I Dipartimento di Scienze Mediche di Base, Neuroscienze e Organi di Senso Università degli Studi di Bari "Aldo Moro"

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Subjects affected by cataract that fulfill eligibility criteria

Description

Inclusion Criteria:

• Previous enrolment in the PSM8 study in the period from March, 1st 2014 to March, 31st 2016 with the following:

  • Any gender and age above 18 years.
  • Cataract or Refractive Lens Exchange (RLE) surgery; will be included patients submitted to conventional phacoemulsification as to femtolaser procedure; no specification regarding corneal incision size and position.
  • Symmetrical preoperative keratometric astigmatism < 1.00 D.
  • Healthy corneas, not surgically treated

Exclusion Criteria:

  • Previous corneal surgery (i.e. pterygium, refractive surgery).
  • Eye diseases with visual acuity < 20/32.
  • Pseudoexfoliation.
  • Abnormal pupil size and position.
  • Use of contact lens 30 days before the preoperative visit.
  • Corneal warpage.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
MINI WELL Ready (SIFI SpA, Italy)
Extended depth of focus intraocular lens implantation
Implantation during cataract surgery of the progressive extended depth of focus intraocular lens for the posterior chamber to replace the crystalline lens in the correction of aphakia in adult patients.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective Refraction
Time Frame: 26 months
26 months
Binocular Defocus Curve
Time Frame: 26 months
Binocular Defocus Curve (+2.0 D to -4.0 D in 0.5 D increments)
26 months
UDVA
Time Frame: 26 months
Monocular and Binocular Uncorrected Distance Visual Acuity (UDVA) at 4m
26 months
CDVA
Time Frame: 26 months
Monocular and Binocular Corrected Distance Visual Acuity (CDVA) at 4m
26 months
UIVA at 100 cm
Time Frame: 26 months
Monocular and Binocular Uncorrected Intermediate Visual Acuity at 100 cm (100% and 10% contrast)
26 months
DCIVA at 100 cm
Time Frame: 26 months
Monocular and Binocular Distance Corrected Intermediate Visual at 100 cm (100% and 10% contrast)
26 months
UIVA at 60 cm
Time Frame: 26 months
Monocular and Binocular Uncorrected Intermediate Visual Acuity at 60 cm (100% and 10% contrast)
26 months
DCIVA at 60 cm
Time Frame: 26 months
Monocular and Binocular Distance Corrected Intermediate Visual Acuity at 60 cm (100% and 10% contrast)
26 months
UNVA
Time Frame: 26 months
Monocular and Binocular Uncorrected Near Visual Acuity at 40cm (100% contrast)
26 months
DCNVA
Time Frame: 26 months
Monocular and Binocular Distance Corrected Near Visual Acuity at 40cm (100% contrast)
26 months
Contrast Sensitivity
Time Frame: 26 months
Binocular Contrast Sensitivity with correction for distance
26 months
Reading Performance
Time Frame: 26 months
Binocular Reading Performance with and without correction for distance
26 months
VR-11R
Time Frame: 26 months
Visual Function -11R Questionnaire from 4 (without difficulties) to 0 (performance impossible due to difficulties)
26 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Complications Rate of postoperative complication
Time Frame: 26 months
26 months
Subjective Posterior Capsule Opacification
Time Frame: 20-26 months
Subjective assessment through slit lamp
20-26 months
Posterior Capsulotomy
Time Frame: 26 months
26 months
Adverse Events including SSIs
Time Frame: 26 months
26 months
Device Deficiencies
Time Frame: 26 months
Descriptive assessment
26 months
Photic Phenomena Assessment
Time Frame: 26 months
Using the Halo and Glare Simulator software
26 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 26, 2020

Primary Completion (Actual)

November 19, 2020

Study Completion (Actual)

November 19, 2020

Study Registration Dates

First Submitted

March 15, 2021

First Submitted That Met QC Criteria

March 15, 2021

First Posted (Actual)

March 17, 2021

Study Record Updates

Last Update Posted (Actual)

March 22, 2021

Last Update Submitted That Met QC Criteria

March 17, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • PSM8 Sub-study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cataract

Clinical Trials on MINI WELL Ready (SIFI SpA, Italy)

Subscribe